Skip to content
★ Sign in to follow
JA

Jack Amin

CFO
Amexdrug Corp
Total declarations
8
Company
1
▲ Purchases (8 ops.)
€3,594
▼ Sales (0 ops.)
—

Latest filing published 19 Nov 2009 for AMEXDRUG CORP, €362.

Insider track record

Disclosed buys
8
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
8
Positive at T+90
0%
Median T+90
-94.1%

Based on 8 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 19 Nov 2009 · 6198 days ago · €362
    -30.9%
    Entry 0.11 · Close at T+365 0.08

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Jack Amin: trading record in brief

Jack Amin discloses dealings in Amexdrug Corp to SEC (Form 4). We count 8 filings; the first trade dates from 18 June 2009 and the latest from 16 September 2009.

On the market, this insider has only ever bought: 8 purchases, €3,594 in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

Half of the purchases are above €362 and half below. Ninety days after publication, 8 purchases show a median change of -94.1%, with the price up in 0% of them. These figures describe past trades and do not predict future prices.

On 19 November 2009 came the latest disclosure, an open-market purchase for €362 in Amexdrug Corp. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Jack Amin

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations8 total
  • ▲
    Pres,CEO,CFO,Sec'y,TreasurerExecutivesAmexdrug Corp
    505 USD0SEC
    500 shares@ US$1.01Common Stock, $0.001 parSEC:0001096906-09-001417:0
    Canonical exit: 16 Sept 2009 (T+90)
  • ▲
    Pres,CEO,CFO,Sec'y,TreasurerExecutivesAmexdrug Corp
    505 USD0SEC
    500 shares@ US$1.01Common Stock, $0.001 parSEC:0001096906-09-001417:1
    Canonical exit: 17 Sept 2009 (T+90)
  • ▲
    Pres,CEO,CFO,Sec'y,TreasurerExecutivesAmexdrug Corp
    1,650 USD0SEC
    1,500 shares@ US$1.10Common Stock, $0.001 parSEC:0001096906-09-001417:2
    Canonical exit: 21 Sept 2009 (T+90)
  • ▲
    Pres,CEO,CFO,Sec'y,TreasurerExecutivesAmexdrug Corp
    700 USD0SEC
    500 shares@ US$1.40Common Stock, $0.001 parSEC:0001096906-09-001417:3
    Canonical exit: 24 Sept 2009 (T+90)
  • ▲
    Pres,CEO,CFO,Sec'y,TreasurerExecutivesAmexdrug Corp
    200 USD0SEC
    100 shares@ US$2.00Common Stock, $0.001 parSEC:0001096906-09-001417:4
    Canonical exit: 4 Oct 2009 (T+90)
  • ▲
    Pres,CEO,CFO,Sec'y,TreasurerExecutivesAmexdrug Corp
    1,350 USD0SEC
    1,000 shares@ US$1.35Common Stock, $0.001 parSEC:0001096906-09-001417:5
    Canonical exit: 5 Nov 2009 (T+90)
  • ▲
    Pres,CEO,CFO,Sec'y,TreasurerExecutivesAmexdrug Corp
    3 USD0SEC
    2 shares@ US$1.35Common Stock, $0.001 parSEC:0001096906-09-001417:6
    Canonical exit: 7 Dec 2009 (T+90)
  • ▲
    Pres,CEO,CFO,Sec'y,TreasurerExecutivesAmexdrug Corp
    135 USD0SEC
    100 shares@ US$1.35Common Stock, $0.001 parSEC:0001096906-09-001417:7
    Canonical exit: 15 Dec 2009 (T+90)

8 of 8 declarations